T-817MA

DRUG3 trials

Sponsors

FUJIFILM Toyama Chemical Co., Ltd.

Conditions

Alzheimer's DiseaseHealthyHepatic ImpairmentMild Cognitive Impairment

Phase 1

PK Study of T-817 in Subjects With Hepatic Impairment

CompletedNCT02693197

FUJIFILM Toyama Chemical Co., Ltd.Healthy, Hepatic Impairment

Start: 2016-02-29End: 2016-08-31Updated: 2017-11-24

Phase 2

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

CompletedNCT00663936

FUJIFILM Toyama Chemical Co., Ltd.Alzheimer's Disease

Start: 2008-04-30End: 2011-06-30Updated: 2013-11-05

Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

CompletedNCT04191486

FUJIFILM Toyama Chemical Co., Ltd.Mild Cognitive Impairment

Start: 2019-12-24End: 2023-03-20Updated: 2023-10-23